Chaitoff and his former colleagues at Harvard University released the examine once the announcement this spring that Medicare would enable protection of semaglutide for enrollees in drug programs if that they had established heart problems. The drug is sold as Wegovy when used for weight loss, and copyright when used for diabetic issues. slumber a